Dexcom Inc (DXCM)

Overview News Price History Option Chain Why DXCM Down? Discussions Forecast Stock Split

Why is Dexcom Inc (DXCM) Stock down?

We've noticed a 9.91% decline in Dexcom Inc (DXCM) stock during the 2024-04-26 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!

11 Oct, 2023:

Shares of DexCom, Inc. (DXCM) dropped by 7.32% from $85.21 to $78.97 in the trading on Wednesday, October 11, 2023. The reason why DXCM stock down is due to a competitor's successful kidney disease prevention drug. However, the stock drop was not exclusive to DexCom, as some other dialysis companies like DaVita and Baxter International also suffered losses. This market turbulence was triggered by Novo Nordisk's early termination of a phase 3 trial for Ozempic (semaglutide), which showed remarkable effectiveness in slowing kidney disease progression in type 2 diabetes and chronic kidney disease patients, potentially disrupting the need for dialysis. This setback compounded DexCom's existing struggles, now that the announcement by Novo Nordisk hurts kidney dialysis provider.

31 Jul, 2023:

DexCom's stock fell 5.91% as investors retreated from the earlier bullish trend.

https://www.benzinga.com/news/23/07/33478042/why-apellis-pharmaceuticals-shares-are-trading-lower-by-around-19-here-are-other-stocks-moving-in-mo